Possible Roles of Cardiac Chymase After Myocardial Infarction in Hamster Hearts

Sun, 1994, Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat, Cardiovasc Res, 28, 1423, 10.1093/cvr/28.9.1423

Passier, 1995, Activation of angiotensin-converting enzyme expression in infarct zone following myocardial infarction, Am J Physiol, 269, H1268

Falkenhahn, 1995, Cellular distribution of angiotensin-converting enzyme after myocardial infarction, Hypertension, 25, 219, 10.1161/01.HYP.25.2.219

Olivetti, 1991, Cellular basis of chronic ventricular remodeling after myocardial infarction in rats, Circ Res, 68, 856, 10.1161/01.RES.68.3.856

Weber, 1997, Extracellular matrix remodeling in heart failure. A role for de novo angiotensin II generation, Circulation, 96, 4065, 10.1161/01.CIR.96.11.4065

Hirsch, 1991, Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure, Circ Res, 69, 475, 10.1161/01.RES.69.2.475

Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001

Pitt, 1997, Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE), Lancet, 349, 747, 10.1016/S0140-6736(97)01187-2

Pfeffer, 1985, Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril, Circulation, 72, 406, 10.1161/01.CIR.72.2.406

Wollert, 1994, Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition, Circulation, 90, 2457, 10.1161/01.CIR.90.5.2457

Milavetz, 1996, Survival after myocardial infarction in rats: captopril versus losartan, J Am Coll Cardiol, 27, 714, 10.1016/0735-1097(95)00506-4

Urata, 1990, Identification of a highly specific chymase as the major angio-tensin II-forming enzyme in the human heart, J Biol Chem, 265, 22348, 10.1016/S0021-9258(18)45712-2

Miyazaki, 2000, Role of chymase on vascular proliferation (Review), J Renin-Angiotensin-Aldesteron System, 1, 23, 10.3317/jraas.2000.004

Reilly, 1982, Rapid conversion of the angiotensin I to angiotensin II by neutrophil and mast cell proteases, J Biol Chem, 275, 8619, 10.1016/S0021-9258(18)34171-1

Takai, 1997, Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta, FEBS Lett, 412, 86, 10.1016/S0014-5793(97)00752-7

Caughey, 2000, Angiotensin II generation by mast cell alpha- and beta-chymases, Biochim Biophys Acta, 1480, 245, 10.1016/S0167-4838(00)00076-5

Takai, 1996, Purification and characterization of angiotensin II-generating chymase from hamster cheek pouch, Life Sci, 58, 591, 10.1016/0024-3205(95)02328-3

Le Trong, 1987, Substrate specificity of the chymotrypsin-like protease in secretory granules isolated from rat mast cells, Proc Natl Acad Sci USA, 84, 364, 10.1073/pnas.84.2.364

Shiota, 1993, Activation of two angiotensin-generating systems in the balloon-injured artery, FEBS Lett, 323, 239, 10.1016/0014-5793(93)81348-4

Shiota, 1997, Chymase is activated in the hamster heart following ventricular fibrosis during the chronic stage of hypertension, FEBS Lett, 406, 301, 10.1016/S0014-5793(97)00295-0

Shiota, 1997, Activation of angiotensin II-forming chymase in the cardiomyopathy hamster heart, J Hypertens, 15, 431, 10.1097/00004872-199715040-00014

Takai, 2000, Inhibition of chymase reduces vascular proliferation in dog grafted veins, FEBS Lett, 467, 141, 10.1016/S0014-5793(00)01125-X

Jin, 1998, Roles of vascular angiotensin converting enzyme and chymase in two-kidney, one clip hypertensive hamsters, J Hypertens, 16, 657, 10.1097/00004872-199816050-00013

Mulder, 1997, Early versus delayed angio-tensin-converting enzyme inhibition in experimental chronic heart failure; effects on survival hemodynamics, and cardiovascular remodeling, Circulation, 95, 1314, 10.1161/01.CIR.95.5.1314

Yamagishi, 1993, Contribution of cardiac renin-angiotensin system to ventricular remodeling in myocardial-infarcted rats, J Mol Cell Cardiol, 25, 1369, 10.1006/jmcc.1993.1149

Yoshiyama, 1999, Effects of candesartan and cilizapril on rats with myocardial infarction assessed by echocardiography, Hypertension, 33, 961, 10.1161/01.HYP.33.4.961

Sun, 1994, Angiotensin II receptor binding following myocardial infarction in the rat, Cardiovasc Res, 28, 1623, 10.1093/cvr/28.11.1623

Beil, 1997, Number, fixation properties, dye-binding and protease expression of duodenal mast cells: comparisons between healthy subjects and patients with gastritis or Crohn’s disease, Histo-chem J, 29, 759, 10.1023/A:1026421303260

Lagunoff, 1976, Characterization of rat mast cell granule protein, Arch Biochem Biophys, 173, 554, 10.1016/0003-9861(76)90292-7

Sayama, 1987, Human skin chymotrypsin-like proteinase chymase. Subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans, J Biol Chem, 262, 6808, 10.1016/S0021-9258(18)48317-2

Keller, 1988, Acute reoxygenation injury in the isolated rat heart: role of residentcardiac mastcells, Circ Res, 63, 1044, 10.1161/01.RES.63.6.1044

Engels, 1995, Transmural changes in mast cell density in rat heart after infarct induction in vivo, J Pathol, 177, 423, 10.1002/path.1711770414

Takao, 2001, Isolation of chymase complexed with physiological inhibitor similar to secretory leukocyte protease inhibitor (SLPI) from hamster cheek pouch tissues, Biochim Biophys Acta, 1545, 146, 10.1016/S0167-4838(00)00272-7

Ahn, 2000, Regulation ofchymase production in human mast cell progenitors, J Allergy Clin Immunol, 106, 321, 10.1067/mai.2000.108107

Maruyama, 2000, Angio-tensin-converting enzyme-independent angiotensin formation in a human model of myocardial ischemia: modulation of norepinephrine release by angiotensin type 1 and angiotensin type 2 receptors, J Pharmacol Exp Ther, 294, 248

Peach, 1997, Renin-angiotensin system: biochemistry and mechanism of action, Physiol Rev, 57, 313, 10.1152/physrev.1977.57.2.313

Harada, 1998, Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias, Circulation, 97, 315, 10.1161/01.CIR.97.4.315

Okamura, 1999, Upregula-tion of renin-angiotensin system during differentiation of monocytes to macrophages, J Hypertens, 17, 537, 10.1097/00004872-199917040-00012

Ohishi, 1997, Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans, J Hypertens, 15, 1295, 10.1097/00004872-199715110-00014

Sun, 1996, Angiotensin-converting enzyme and myofibroblasts during tissue repair in the rat heart, J Mol Cell Cardiol, 28, 851, 10.1006/jmcc.1996.0080

Raya, 1991, Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model of heart failure, Am J Hypertens, 4, 334S, 10.1093/ajh/4.4.334S

Urata, 1993, Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase, Eur Heart J 14, Suppl, 1, 177

Hall, 1997, Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study, Lancet, 349, 1493, 10.1016/S0140-6736(97)04442-5

Kober, 1995, Clinical characteristics and mortality of patients screened for entry into the Trandolapril Cardiac Evaluation (TRACE) Study, Am J Cardiol, 76, 1, 10.1016/S0002-9149(99)80791-7